Mitigation of Exercise Oscillatory Ventilation Score by Cardiac Resynchronization Therapy
Ivan Cundrle1, Bruce D Johnson2, Robert F Rea2
1Department of Anesthesiology and Intensive Care, St. Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
Cardiac resynchronization therapy (CRT) improved exercise oscillatory ventilation (EOV) scores in heart failure patients. This improvement was linked to better CO2 chemosensitivity, suggesting CRT can stabilize ventilatory control.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Biomedical Engineering
Background:
- Exercise oscillatory ventilation (EOV) is a sign of unstable ventilatory control in advanced heart failure (HF).
- EOV is linked to a worse prognosis in HF patients.
- Cardiac resynchronization therapy (CRT) is a treatment for HF.
Purpose of the Study:
- To assess the impact of CRT on EOV using a novel EOV score.
- To explore the relationship between CRT, EOV, and CO2 chemosensitivity.
Main Methods:
- A post hoc analysis of 35 HF patients undergoing CRT.
- Cardiopulmonary exercise testing and CO2 chemosensitivity measurements before and after CRT.
- Calculation of an EOV score to quantify oscillatory ventilation.
Main Results:
- CRT improved EOV scores in 63% of patients.
- In responders, CRT led to significant improvements in left ventricular ejection fraction, left atrial volume, brain natriuretic peptide, and CO2 chemosensitivity.
- Improved CO2 chemosensitivity was the primary predictor of EOV score improvement post-CRT.
Conclusions:
- CRT can mitigate the EOV score in heart failure patients.
- The improvement in EOV is associated with enhanced CO2 chemosensitivity.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease III: Medical Management
Aortic Regurgitation III: Medical Management
